Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

“Golden Girls” Mice Are Key to Longevity Research

There has been a heightened interest in longevity research. Some have noted that older billionaires such as Bill Gates, Michael Bloomberg, Richard Branson and others have been investing heavily into biopharma companies focused on aging and aging-related diseases.

Read More »

Women’s History Month: Top Influential Women in Biopharma

March is National Women’s Month, and BioSpace recognized these 10 women as being especially influential in the biopharma industry.

Read More »

HCB Health Structures Firm, Invests in Talent to Meet Client & Growth Needs

HCB Health, one of the leading independent healthcare communications agencies in the United States, announced the creation of three internal business units to best serve an increasingly diverse set of clients and to help manage the firm’s rapid growth.

Read More »

BioSpace Movers and Shakers: March 1, 2019

Chief Commercial Officer Steven Hoerter resigned his role at Agios Pharmaceuticals to accept a role as chief executive officer at an oncology-focused biotechnology company.

Read More »

Immunomedics’ CEO and President Steps Down

Morris Plains, N.J.-based Immunomedics announced that the company’s president, chief executive officer and board member, Michael Pehl, was stepping down for personal reasons.

Read More »

Menopause and Estrogen Decline Could Show a Link to Alzheimer’s Disease

As pharma companies struggle with developing a treatment for Alzheimer’s disease, researchers continue to find evidence that links the dreaded form of dementia to other medical and health issues. The latest news suggests a potential link between Alzheimer’s and menopause.

Read More »

Israeli biopharma firm BiomX raises $32 million in private funding

Israeli biopharma firm BiomX raised $32 million in a private funding round that will primarily be used to advance the company’s drug candidates for the treatment of acne and inflammatory bowel disease (IBD).

Read More »

Starboard gauges Bristol-Myers shareholder support for Celgene deal

Activist hedge fund Starboard Value LP asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb Co. shareholders for the U.S. drug maker’s $74 billion deal to buy Celgene Corp., people familiar with the matter said.

Read More »

Top 10 Pipelines To Watch: 2019 Annual Report

The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.

Read More »

Billions of Dollars This Week Show AI Is in BioPharma’s Present and Future

The tools of artificial intelligence continue to be essential elements for the biopharma industry. Companies across the sphere have invested heavily into the technology and this week, several more announced deals that bank on the use of artificial intelligence.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom